Top Markets
Coin of the day
MOLOGEN Lifescience AG MOLOGEN Lifescience AG

MOLOGEN Lifescience AG

U1DA
Rank in Stocks #40050
Finchain Capital Partners AG functions as an investment firm, concentrating its... Finchain Capital Partners AG functions as an investment firm, concentrating its capital deployment on early-stage companies, specifically during their seed, Series A, and Series B funding rounds. The company was established on February 27, 2015, and is based in Dusseldorf, Germany.
Share Price
$3.32
Last synced: 2026-08-13
Market Cap
$261.55K
Change (1 day)
0.00%
Change (1 year)
42.54%
Country
DE
Trade MOLOGEN Lifescience AG (U1DA)
P/B ratio for MOLOGEN Lifescience AG (U1DA)
P/B ratio as of 2026 TTM: 0
According to MOLOGEN Lifescience AG latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for MOLOGEN Lifescience AG from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
2.9853 -
US
11.1001 -
US
- -
SE
2.9787 -
US
10.2081 -
US